Back to top
more

Innospec (IOSP)

(Delayed Data from NSDQ)

$129.49 USD

129.49
89,155

+1.70 (1.33%)

Updated May 24, 2024 04:00 PM ET

After-Market: $129.43 -0.06 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (150 out of 250)

Industry: Chemical - Diversified

Better trading starts here.

Balance Sheet

Research for IOSP

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Innospec Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 204 147 142 105 76
Receivables 360 335 285 221 292
Notes Receivable 0 0 0 0 0
Inventories 300 373 278 220 245
Other Current Assets 22 18 24 20 18
Total Current Assets 886 873 728 566 630
Net Property & Equipment 268 221 214 211 199
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 10 6 6 8 9
Intangibles 457 404 422 447 477
Deposits & Other Assets 41 55 165 126 122
Total Assets 1,707 1,604 1,571 1,397 1,469
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 164 165 149 99 122
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 1 1
Accrued Expenses 186 203 167 130 154
Income Taxes Payable 4 18 4 6 10
Other Current Liabilities 5 5 5 7 6
Total Current Liabilities 372 406 337 252 304
Mortgages 0 0 0 0 0
Deferred Taxes/Income 34 26 61 47 50
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 59
Non-Current Capital Leases 0 0 0 0 1
Other Non-Current Liabilities 121 100 117 124 116
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 558 563 538 453 550
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 361 354 347 336 330
Retained Earnings 1,028 924 823 759 756
Other Equity -146 -143 -46 -57 -74
Treasury Stock 94 95 91 93 93
Total Shareholder's Equity 1,150 1,040 1,033 945 919
Total Liabilities & Shareholder's Equity 1,707 1,604 1,571 1,397 1,469
Total Common Equity 1,150 1,040 1,033 945 919
Shares Outstanding 24.80 24.70 24.60 24.50 24.50
Book Value Per Share 46.35 42.12 41.99 38.57 37.51

Fiscal Year End for Innospec Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 270 204 207 166 148
Receivables 318 360 305 311 342
Notes Receivable 0 0 0 0 0
Inventories 304 300 332 357 366
Other Current Assets 20 22 20 21 19
Total Current Assets 913 886 864 855 875
Net Property & Equipment 269 268 245 242 234
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 10 10 6 6 6
Intangibles 455 457 406 407 407
Deposits & Other Assets 42 41 56 55 54
Total Assets 1,733 1,707 1,619 1,611 1,624
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 166 164 146 158 178
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 164 186 165 175 164
Income Taxes Payable 17 4 15 14 20
Other Current Liabilities 5 5 5 4 5
Total Current Liabilities 365 372 344 365 382
Mortgages 0 0 0 0 0
Deferred Taxes/Income 34 34 26 27 27
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 118 91 92 101
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 547 558 491 516 544
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 362 361 359 357 355
Retained Earnings 1,070 1,028 1,008 969 957
Other Equity -153 -146 -145 -137 -138
Treasury Stock 93 94 94 94 94
Total Shareholder's Equity 1,186 1,150 1,128 1,095 1,081
Total Liabilities & Shareholder's Equity 1,733 1,707 1,619 1,611 1,624
Total Common Equity 1,186 1,150 1,128 1,095 1,081
Shares Outstanding 24.90 24.80 24.80 24.80 24.80
Book Value Per Share 47.64 46.35 45.49 44.15 43.57